TransAct Technologies Reports Strong FY25 Results, Guides for Continued Growth & Profitability in 2026
summarizeSummary
TransAct Technologies reported significantly improved financial results for Q4 and full year 2025, with strong revenue growth and a return to positive adjusted EBITDA, alongside optimistic guidance for 2026.
check_boxKey Events
-
Strong Full Year 2025 Performance
Net sales increased 19% to $51.5 million, and FST recurring revenue grew 14% to $12.3 million for the full year 2025.
-
Return to Adjusted EBITDA Profitability
Full year 2025 Adjusted EBITDA reached $1.2 million, a significant improvement from a $(1.5) million loss in 2024.
-
Positive 2026 Financial Outlook
The company expects 2026 net sales between $55 million and $57 million and adjusted EBITDA between $800 thousand and $1.5 million.
-
Reduced Net Loss
Full year 2025 net loss significantly narrowed to $(1.2) million, compared to $(9.9) million in 2024 (which included a large non-cash tax charge).
auto_awesomeAnalysis
TransAct Technologies delivered a strong performance in 2025, marked by substantial revenue growth in both the fourth quarter and full year, particularly in its Food Service Technology (FST) recurring revenue segment. The company successfully turned its adjusted EBITDA positive for the full year 2025, a significant improvement from the prior year's loss. This positive momentum is expected to continue into 2026, with management guiding for further net sales growth and sustained adjusted EBITDA profitability. This financial turnaround, coupled with the strategic focus on high-margin software sales, provides a positive outlook for the company, especially as the stock trades near its 52-week low.
At the time of this filing, TACT was trading at $3.20 on NASDAQ in the Technology sector, with a market capitalization of approximately $35.5M. The 52-week trading range was $3.12 to $5.70. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.